InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Attovia Therapeutics, Inc.

ATTO
United States Fiscal year ends December CIK 0002058707
16.21
-0.61%
Close, 9 Oct 2026 · USD
Alert on the numbers Alert on insider trades

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
16.21 on 9 Oct 2026
26 21 16 Aug 2026 Sep 2026 Oct 2026 5 Aug 2026 $21.90 6 Aug 2026 $20.38 7 Aug 2026 $20.17 10 Aug 2026 $19.84 11 Aug 2026 $18.65 12 Aug 2026 $18.06 13 Aug 2026 $19.18 14 Aug 2026 $19.86 17 Aug 2026 $22.71 18 Aug 2026 $23.24 19 Aug 2026 $22.14 20 Aug 2026 $20.21 21 Aug 2026 $20.80 24 Aug 2026 $20.62 25 Aug 2026 $19.31 26 Aug 2026 $19.55 27 Aug 2026 $21.46 28 Aug 2026 $20.70 31 Aug 2026 $21.40 1 Sep 2026 $22.22 2 Sep 2026 $23.13 3 Sep 2026 $24.20 4 Sep 2026 $25.55 8 Sep 2026 $23.66 9 Sep 2026 $22.86 10 Sep 2026 $22.53 11 Sep 2026 $22.79 14 Sep 2026 $24.52 15 Sep 2026 $23.70 16 Sep 2026 $22.25 17 Sep 2026 $22.73 18 Sep 2026 $22.14 21 Sep 2026 $21.30 22 Sep 2026 $20.83 23 Sep 2026 $18.52 24 Sep 2026 $18.17 25 Sep 2026 $17.78 28 Sep 2026 $17.65 29 Sep 2026 $18.16 30 Sep 2026 $17.14 1 Oct 2026 $17.79 2 Oct 2026 $17.17 5 Oct 2026 $18.00 6 Oct 2026 $17.50 7 Oct 2026 $16.42 8 Oct 2026 $16.31 9 Oct 2026 $16.21 GOLDMAN SACHS GROUP INC Former 10% Owner Bought $1.79M 5 Aug 2026 · at $21.00 WALSH COLIN Director Bought $1.79M 5 Aug 2026 · at $21.00 GOLDMAN SACHS GROUP INC Former 10% Owner Sold at will $2.25M 5 Aug 2026 · at $21.28 · 100% of stake WALSH COLIN Director Sold at will $2.25M 5 Aug 2026 · at $21.28 · 100% of stake Redmile Group, LLC 10% owner Bought $3.40M 6 Aug 2026 · at $17.00 · 25.5% of stake Sanofi 10% owner Bought $5.10M 6 Aug 2026 · at $17.00 · 38.3% of stake venBio Global Strategic Fund … 10% owner Bought $6.50M 6 Aug 2026 · at $17.00 · 10.1% of stake Redmile Group, LLC 10% owner Bought $6.80M 6 Aug 2026 · at $17.00 · 51.1% of stake GOLDMAN SACHS GROUP INC Former 10% Owner Bought $8.50M 6 Aug 2026 · at $17.00 · 19.8% of stake WALSH COLIN Director Bought $8.50M 6 Aug 2026 · at $17.00 · 19.8% of stake Frazier Life Sciences XI, L.P. 10% owner Bought $10.00M 6 Aug 2026 · at $17.00 · 10.6% of stake
9 buys2 sales at will0 planned sales

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
6 Aug 2026 Frazier Life Sciences XI, L.P.
10% owner
 Bought $10.00M 10.6%
6 Aug 2026 WALSH COLIN
Director
 Bought $8.50M 19.8%
6 Aug 2026 GOLDMAN SACHS GROUP INC
Former 10% Owner
 Bought $8.50M 19.8%
6 Aug 2026 Redmile Group, LLC
10% owner
 Bought $6.80M 51.1%
6 Aug 2026 venBio Global Strategic Fund IV, L.P.
10% owner
 Bought $6.50M 10.1%
6 Aug 2026 Sanofi
10% owner
 Bought $5.10M 38.3%